NantKwest to Present at Upcoming Investment and Healthcare Conferences

NantKwest announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the month of March and April 2018.

CULVER CITY, Calif.--(BUSINESS WIRE)-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the month of March and April 2018. The presentations and one-on-one discussions will feature a science and business overview, along with a clinical update provided by company management.

Conference Details:

Event: Roth Capital 30th Annual Investment Conference
Date/Time: Tuesday, March 13, 2018, one-on-one meetings
Location: Laguna Niguel, CA
Event: Cowen & Company 38th Annual Healthcare Conference
Date/Time: Wednesday, March 14, 2018, one-on-one meetings
Location: Boston, MA
Event: Oppenheimer & Company 28th Annual Healthcare Conference
Date/Time: Tuesday, March 20, 2018, one-on-one meetings
Location: New York, NY
Event: Needham & Company 17th Annual Healthcare Conference
Date/Time: Wednesday, March 28, 2018, presentation at 12:45pm
Location: New York, NY
Event: Hanson Wade Innate Killer Summit
Date/Time: Thursday, March 29, 2018, presentation at 12:50pm
Location: New York, NY
Event: Jefferies IO Cell Therapy Investment Conference
Date/Time: Tuesday, April 3, 2018, presentation at 11:40am
Location: Boston, MA

MORE ON THIS TOPIC